LORENA NARVAEZ: Open Payments
NPI 1376685651 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,585 in 123 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $1,771 · 2025 $3,585
Food & beverage: $3,501Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $708 |
| Madrigal Pharmaceuticals | 10 | $384 |
| ABBVIE INC. | 16 | $322 |
| GENZYME CORPORATION | 12 | $316 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $300 |
| Lilly USA, LLC | 10 | $293 |
| Phathom Pharmaceuticals, Inc. | 6 | $251 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $237 |
| Regeneron Healthcare Solutions, Inc. | 6 | $172 |
| QOL Medical, LLC | 5 | $144 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, OMVOH, ENTYVIO, VOQUEZNA, XIFAXAN, Sucraid.
Industry payments across GA — which companies pay providers there.
